The capital accelerates deployment of cost‑control technology in a fragmented procurement market, improving hospital margins and regulatory compliance.
The U.S. healthcare system spends billions annually on medical devices, yet fragmented ordering processes generate costly errors and off‑contract purchases. Helia Care’s cloud‑based SaaS platform tackles this inefficiency by automatically aligning clinicians’ orders with pre‑negotiated supplier contracts, creating a single source of truth for pricing and compliance. By embedding a two‑sided network that brings hospitals and vetted vendors onto the same digital stage, the solution not only streamlines procurement but also provides real‑time analytics to flag pricing anomalies before they become financial losses.
The recent $3 million financing round, anchored by In Revenue Capital and Habanero Ventures, gives Helia Care the runway to scale its engineering team and broaden its market footprint beyond Arizona. Early‑stage investors are increasingly targeting health‑tech ventures that promise measurable cost reductions, and Helia’s focus on fraud, waste, and abuse aligns with payer and regulator priorities. The capital infusion will fund product enhancements, integration with electronic health record systems, and a sales push aimed at mid‑size health systems that have yet to adopt sophisticated procurement tools.
Industry analysts predict that digital procurement platforms could capture up to 15 % of the $150 billion medical device spend within the next five years. Helia Care’s dual‑sided model positions it to compete with legacy ERP providers while offering a more agile, cloud‑native experience. As hospitals tighten budgets and compliance scrutiny intensifies, vendors that deliver transparent pricing and automated contract enforcement will gain a decisive edge. Helia’s next phase will likely involve strategic partnerships that embed its network directly into hospital purchasing workflows.
Helia Care, a Scottsdale-based SaaS provider for healthcare supply chain and billing, announced a $3 million funding round. The round was backed by In Revenue Capital and Habanero Ventures and will be used to expand operations and development. The platform aligns clinical ordering with supplier contracts to reduce errors and pricing discrepancies.
Comments
Want to join the conversation?
Loading comments...